ProCE Banner Activity

Single-Agent PARP Inhibitors in Prostate Cancer

Slideset

Download this slideset from a live symposium to learn more about HRR mutations and PARP inhibitor monotherapy in metastatic prostate cancer.

Released: January 24, 2024

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Merck & Co., Inc., Rahway, NJ, USA.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Merck & Co., Inc., Rahway, NJ, USA